Eukaryotic translation initiation factor 3 subunit C is associated with acquired resistance to erlotinib in non-small cell lung cancer

The acquisition of resistance to EGFR tyrosine kinase inhibitors (EGFR-TKIs) is one of the major problems in the pharmacotherapy against non-small cell lung cancers; however, molecular mechanisms remain to be fully elucidated. Here, using a newly-established erlotinib-resistant cell line, PC9/ER, fr...

Descripción completa

Detalles Bibliográficos
Autores principales: Shintani, Takuya, Higashisaka, Kazuma, Maeda, Makiko, Hamada, Masaya, Tsuji, Ryosuke, Kurihara, Koudai, Kashiwagi, Yuri, Sato, Atsuhiro, Obana, Masanori, Yamamoto, Ayaha, Kawasaki, Keisuke, Lin, Ying, Kijima, Takashi, Kinehara, Yuhei, Miwa, Yoshihiro, Maeda, Shinichiro, Morii, Eiichi, Kumanogoh, Atsushi, Tsutsumi, Yasuo, Nagatomo, Izumi, Fujio, Yasushi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2018
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6331022/
https://www.ncbi.nlm.nih.gov/pubmed/30680067
http://dx.doi.org/10.18632/oncotarget.26494

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6331022/
https://www.ncbi.nlm.nih.gov/pubmed/30680067
http://dx.doi.org/10.18632/oncotarget.26494

Ejemplares similares